Chronic viral hepatitis and TNF-α blockade

被引：19
作者：
Raftery, G.
Griffiths, B.
Kay, L.
Kane, D.
机构：
[1] Freeman Rd Hosp, Newcastle Upon Tyne NE7 7DN, Tyne & Wear, England
[2] Adelaide & Meath Hosp, Dublin 24, Ireland
来源：
RHEUMATOLOGY | 2007年 / 46卷 / 08期
关键词：
D O I：
10.1093/rheumatology/kem082
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1381 / 1381
页数：1
相关论文
共 4 条
[1]   Hepatitis B virus (HBV) reactivation with immunosuppressive therapy in rheumatic diseases: assessment and preventive strategies [J].
Calabrese, L. H. ;
Zein, N. N. ;
Vassilopoulos, D. .
ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 (08) :983-989
[2]   Clinical outcome of HBeAg-negative chronic hepatitis B in relation to virological response to lamivudine [J].
Di Marco, V ;
Marzano, A ;
Lampertico, P ;
Andreone, P ;
Santantonio, T ;
Ahnasio, PL ;
Rizzetto, M ;
Craxì, A .
HEPATOLOGY, 2004, 40 (04) :883-891
[3]  
RAFTERY G, 2004, ANN RHEUM DIS S, V64, P2
[4]   Safety of anti-TNF-α therapy in rheumatoid arthritis and spondylarthropathies with concurrent B or C chronic hepatitis [J].
Roux, C. H. ;
Brocq, O. ;
Breuil, V. ;
Albert, C. ;
Euller-Ziegler, L. .
RHEUMATOLOGY, 2006, 45 (10) :1294-1297
1